Dr. Joel W Levitt, M.D. Otolaryngology - Pediatric Otolaryngology Medicare: Medicare Enrolled Practice Location: 769 Northfield Ave, Suite Ll2, West Orange, NJ 07052 Phone: 973-731-2100 Fax: 973-731-2188 |
Dr. Reynaldo S Paraiso Jr., D.O. Otolaryngology - Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 741 Northfield Ave, Suite 104, West Orange, NJ 07052 Phone: 973-243-0600 Fax: 973-243-0707 |
Dr. Eric Mark Joseph, MD Otolaryngology - Facial Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1500 Pleasant Valley Way, Suite 206, West Orange, NJ 07052 Phone: 973-325-1155 Fax: 973-325-8668 |
Dr. Howard Martin Berg, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Old Short Hills Road, Suite 520, West Orange, NJ 07052 Phone: 973-731-5400 Fax: 973-669-0805 |
News Archive
New research suggests patients nearing the end of their lives because of a "life-limiting illness" such as cancer or heart disease may not feel medically abandoned if their doctor wants to take them off the statins that control their cholesterol.
The cause of neuronal death in Parkinson's disease is still unknown, but a new study proposes that neurons may be mistaken for foreign invaders and killed by the person's own immune system, similar to the way autoimmune diseases like type I diabetes, celiac disease, and multiple sclerosis attack the body's cells.
A novel cell transplantation method to treat corneal endothelial diseases such as bullous keratopathy using a nano-composite gel sheet developed by Japanese scientists was granted Indian patent to GN Corporation (GNC), Japan.
The UCLA Health System has launched the new UCLA Hand Transplantation Program, the first of its kind on the West Coast and only the fourth such center in the United States. The program will help those who have suffered the traumatic loss of a hand or forearm and allow them to regain function and improve their quality of life. Qualified candidates are now being sought for a clinical study of the procedure.
Scientists from UCL (University College London) have designed a chemical compound that has reduced the growth of pancreatic cancer tumours by 80 percent in treated mice.
› Verified 9 days ago